Optimizing experimental research in respiratory diseases: an ERS Statement

M. Kolb (Hamilton (ON), Canada)

Source: International Congress 2018 – Organoids and pluripotent stem cells
Session: Organoids and pluripotent stem cells
Session type: Symposium
Number: 279

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kolb (Hamilton (ON), Canada). Optimizing experimental research in respiratory diseases: an ERS Statement. International Congress 2018 – Organoids and pluripotent stem cells

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Optimising experimental research in respiratory diseases: an ERS statement
Source: Eur Respir J, 51 (5) 1702133; 10.1183/13993003.02133-2017
Year: 2018



Optimising experimental research in respiratory diseases: an ERS statement
Source: Guideline 2018
Year: 2018

ERS statement on paediatric long-term noninvasive respiratory support
Source: Guideline 2022
Year: 2021

ATS/ERS Statement on occupational burden of respiratory disease
Source: International Congress 2019 – Occupational and epidemiology Grand Round
Year: 2019


ERS Statement: Exercise testing in the evaluation of interventional efficacy
Source: International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit
Year: 2015



ERS Statement on standardisation of cardiopulmonary exercise testing (CPET) in chronic lung diseases
Source: International Congress 2019 – Clinical Year in review
Year: 2019


ERS Statement: Smoking cessation in COPD and other pulmonary disorders
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015



ERS Statement: Diagnosis and treatment of primary spontaneous pneumothorax
Source: International Congress 2015 – ERS Task Forces and Guidelines: procedures, methodology and publication
Year: 2015



ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
Source: Eur Respir J, 55 (2) 1901208; 10.1183/13993003.01208-2019
Year: 2020



ERS Statement on Interventional bronchoscopy in children
Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology
Year: 2017


Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Eur Respir J 2016; 48: 648-663
Year: 2016




Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Guideline 2017
Year: 2017

Genetic associations is part of the personalised answer: Report of ERS Statement on AATD
Source: International Congress 2017 – Personalised care for emphysema in COPD
Year: 2017


ERS Statement: Idiopathic pulmonary fibrosis
Source: International Congress 2015 – ERS Task Forces and Guidelines: procedures, methodology and publication
Year: 2015



ERS Statement on respiratory mechanics and muscle testing at rest and during exercise in chronic lung disorders
Source: International Congress 2019 – Clinical Year in review
Year: 2019


ERS Statement on Protracted Bacterial Bronchitis
Source: International Congress 2017 – Non-CF bronchiectasis in children
Year: 2017


ERS/TSANZ Statement on the management of reproduction and pregnancy in women with airways diseases
Source: Guideline 2020
Year: 2020

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Source: Eur Respir J, 51 (5) 1702678; 10.1183/13993003.02678-2017
Year: 2018



ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Source: Guideline 2018
Year: 2018

ERS/EAN/ESO/ESRS Statement on the impact of sleep disorders on risk and outcome of stroke
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019